Sec. 1091. Improvements to transparency of the pricing of diagnostic testing for COVID–19
381 words·~2 min read·
/bill/116/hr/14/ih/section-1091A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Section 3202 of the CARES Act ( Public Law 116–136 ) is amended— in subsection (b)— in the heading, by inserting after and Related Items and Services ; Diagnostic Testing for COVID–19 in paragraph (1)— by striking a diagnostic test for COVID–19 and inserting a test, item, or service described in section 6001(a) of division F of the Families First Coronavirus Response Act ( ; and Public Law 116–127 ) by striking such test and inserting such test, item, or service ; and in paragraph (2), by striking a diagnostic test for COVID–19 and inserting a test, item, or service described in section 6001(a) of division F of the Families First Coronavirus Response Act ( ; and Public Law 116–127 ) by adding at the end the following new subsections:
Not later than 30 days after the date of the enactment of this subsection, the Secretary of Health and Human Services shall survey providers subject to the requirement under subsection
(b)regarding the cash prices referred to in such subsection. In carrying out paragraph (1), the Secretary shall survey a sample of providers that is representative of the diversity of sizes, geographic locations, and care settings (such as hospitals, laboratories, and independent freestanding emergency departments) in which diagnostic testing for COVID–19 is performed. The Secretary shall ensure that consumers have a method to submit complaints to the Department of Health and Human Services that identify providers that— may be in violation of subsection (b); and have not made public a cash price in accordance with such subsection. Not later than 60 days after the date of the enactment of this subsection, the Secretary of Health and Human Services shall publish on the internet website of the Department of Health and Human Services a report on cash prices for items and services published under subsection (b)(1) during the period beginning on the date of the enactment of this Act and ending on the date of the enactment of this subsection, which shall include— the percentage of providers that comply with the requirement under such subsection; the average cash price for each such item and service published under such subsection; and any providers identified pursuant to paragraph
(2)or
(3)of subsection
(c)and found to be in violation of such requirement. .
Connectionstraces to 2
Traces to 2 documents
Citation graph
cites case law
Sec. 1091
Improvements to transparency of the pricing of diagnostic testing for COVID–19
Cites 2Cited by 0 across 0 sources